BORTEZOMIB AND HIGH-DOSE MELPHALAN AS A NOVEL CONDITIONING REGIMEN FOR PATIENTS WITH POEMS SYNDROME UNDERGOING AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION

被引：0
|
作者：
Tang, X. [1 ]
Shi, X. [1 ]
Hu, X. [1 ]
Xue, S. [1 ]
Qiu, H. [1 ]
Han, Y. [1 ]
Yan, L. [1 ]
Zhou, H. [1 ]
Liu, Y. [1 ]
Gu, B. [1 ]
Sun, A. [1 ]
Wu, D. [1 ]
机构：
[1] Jiangsu Inst Hematol, Suzhou, Jiangsu, Peoples R China
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.153
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
131
引用
收藏
页码：S202 / S202
页数：1
相关论文
共 50 条
  • [1] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
    Miyamoto, Toshihiro
    Yoshimoto, Goichi
    Kamimura, Tomohiko
    Muta, Tsuyoshi
    Takashima, Shuichiro
    Ito, Yoshikiyo
    Shiratsuchi, Motoaki
    Choi, Ilseung
    Kato, Koji
    Takenaka, Katsuto
    Iwasaki, Hiromi
    Takamatsu, Yasushi
    Teshima, Takanori
    Akashi, Koichi
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (03) : 337 - 345
  • [2] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
    Toshihiro Miyamoto
    Goichi Yoshimoto
    Tomohiko Kamimura
    Tsuyoshi Muta
    Shuichiro Takashima
    Yoshikiyo Ito
    Motoaki Shiratsuchi
    Ilseung Choi
    Koji Kato
    Katsuto Takenaka
    Hiromi Iwasaki
    Yasushi Takamatsu
    Takanori Teshima
    Koichi Akashi
    [J]. International Journal of Hematology, 2013, 98 : 337 - 345
  • [3] Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Rodriguez, Tulio E.
    Hari, Parameswaran
    Stiff, Patrick J.
    Smith, Scott E.
    Sterrenberg, Danielle
    Vesole, David H.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (08) : 1391 - 1396
  • [4] Bortezomib after high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with multiple myeloma: A comparison with the historical conditioning regimen with melphalan alone
    Ferini, G. A.
    Arbelbide, J. A.
    Basquiera, A. L.
    Nucifora, E.
    Schutz, N.
    Otero, V.
    Fantl, D.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S461 - S462
  • [5] Comparison of conditioning regimen toxicities among autologous stem cell transplantation eligible multiple myeloma patients: High-dose melphalan versus high-dose melphalan and bortezomib
    Aypar, Eda
    Izzettin, Fikret Vehbi
    Aki, Sahika Zeynep
    Sancar, Mesut
    Yegin, Zeynep Arzu
    Turkoz-Sucak, Gulsan
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (04) : 281 - 289
  • [6] BORTEZOMIB AND HIGH-DOSE MELPHALAN AS CONDITIONING REGIMEN BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: EXPERIENCE IN A UNIVERSITARY HOSPITAL
    Dunia, D. M.
    Dolores, M.
    Dolores, S.
    Nuria, G.
    Miguel, D.
    Jaime, A.
    Helga, G.
    Alejandro, V.
    Sonia, H.
    Blanca, P.
    [J]. HAEMATOLOGICA, 2016, 101 : 862 - 862
  • [7] Busulfan and melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Jin Seok
    Min, Chang-Ki
    Kim, Kihyun
    Choi, Yunsuk
    Eom, Hyeon-Seok
    Joo, Young Don
    Kim, Sung-Hyun
    Kwak, Jae-Yong
    Kang, Hye Jin
    Lee, Jae Hoon
    Lee, Ho Sup
    Mun, Yeung-Chul
    Moon, Joon Ho
    Sohn, Sang Kyun
    Park, Seong Kyu
    Park, Yong
    Shin, Ho-Jin
    Yoon, Sung-Soo
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 262 - 263
  • [8] BORTEZOMIB AND HIGH-DOSE MELPHALAN AS CONDITIONING REGIMEN BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: EXPERIENCE IN A UNIVERSITARY HOSPITAL
    de Miguel, D.
    Morales, D.
    San Roman, I.
    Golbano, N.
    Diaz, M.
    Arbeteta, J.
    Herrero, S.
    Subira, D.
    PInedo, B.
    [J]. HAEMATOLOGICA, 2012, 97 : 622 - 622
  • [9] High-Dose Busulfan and Melphalan as Conditioning Regimen for Autologous Peripheral Blood Progenitor Cell Transplantation in High-Risk Neuroblastoma Patients
    Molina, Blanca
    Alonso, Laura
    Gonzalez-Vicent, Marta
    Andion, Maitane
    Hernandez, Carmen
    Lassaletta, Alvaro
    Cormenzana, Maria
    Lopez-Ibor, Blanca
    Villa, Marta
    Molina, Javier
    Diaz, Miguel A.
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (02) : 115 - 123
  • [10] A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning Regimen for Salvage Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma
    Biran, Noa
    Rowley, Scott D.
    Vesole, David H.
    Zhang, Shijia
    Donato, Michele L.
    Richter, Joshua
    Skarbnik, Alan P.
    Pecora, Andrew
    Siegel, David S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (12) : 2165 - 2171
12345